Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis. N Engl J Med. 2016 Jul 28; 375(4):345-56.
View in:
PubMed
subject areas
Adult
Antibodies, Monoclonal, Humanized
Candidiasis
Female
Humans
Inflammatory Bowel Diseases
Intention to Treat Analysis
Male
Middle Aged
Neutropenia
Psoriasis
Severity of Illness Index
authors with profiles
Kenneth Gordon